Northern Trust’s Telomir Pharmaceuticals TELO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$126K Buy
104,894
+43,362
+70% +$50.9K ﹤0.01% 4044
2026
Q2
$78.8K Buy
61,532
+19,688
+47% +$25.6K ﹤0.01% 4179
2026
Q1
$54.4K Hold
41,844
– – ﹤0.01% 4230
2025
Q4
$55.7K Hold
41,844
– – ﹤0.01% 4262
2025
Q3
$58.2K Hold
41,844
– – ﹤0.01% 4258
2025
Q2
$52.3K Sell
41,844
-112,228
-73% -$259K ﹤0.01% 4225
2025
Q1
$498K Buy
154,072
+2,444
+2% +$10.7K ﹤0.01% 3581
2024
Q4
$625K Buy
151,628
+102,948
+211% +$485K ﹤0.01% 3577
2024
Q3
$313K Buy
+48,680
New +$237K ﹤0.01% 3720

Other funds holding TELO

Northern Trust's TELO Position: Q3 2026 in Review

Northern Trust increased its Telomir Pharmaceuticals (TELO) stake by 70% in Q3 2026, buying an estimated $50.9K and bringing the position to 104,894 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #4044.

Northern Trust first reported a position in TELO in Q3 2024 and has held it in 9 quarters since. The position peaked at $625K in Q4 2024. 26 funds tracked by Wall St. Rank hold TELO as of Q3 2026.

  • Northern Trust held 104,894 shares of Telomir Pharmaceuticals worth $126K as of Q3 2026.
  • Northern Trust bought 43,362 Telomir Pharmaceuticals shares in Q3 2026, an estimated $50.9K.
  • Telomir Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q3 2026, its #4044 holding.
  • Northern Trust first reported a position in Telomir Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
  • Northern Trust's Telomir Pharmaceuticals position peaked at $625K in Q4 2024.
  • 26 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q3 2026.

Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.